| NDC包装代码 | 产品NDC | 产品类型 | 商品名 | 通用名 | 剂型 | 给药途径 | 上市日期 | 结束日期 | 市场类别 | 申请号 | 标签持有者 | 活性成分 | 规格 | 包装描述 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 70121-1586-3 | 70121-1586 | HUMAN PRESCRIPTION DRUG | Verapamil Hydrochloride | Verapamil Hydrochloride | INJECTION, SOLUTION | INTRAVENOUS | 20180717 | N/A | ANDA | ANDA210994 | Amneal Pharmaceuticals LLC | VERAPAMIL HYDROCHLORIDE | 2.5 mg/mL | 5 VIAL in 1 CARTON (70121-1586-3) / 4 mL in 1 VIAL (70121-1586-1) |
| 70121-1585-5 | 70121-1585 | HUMAN PRESCRIPTION DRUG | Verapamil Hydrochloride | Verapamil Hydrochloride | INJECTION, SOLUTION | INTRAVENOUS | 20180717 | N/A | ANDA | ANDA210994 | Amneal Pharmaceuticals LLC | VERAPAMIL HYDROCHLORIDE | 2.5 mg/mL | 25 VIAL in 1 CARTON (70121-1585-5) / 2 mL in 1 VIAL (70121-1585-1) |